The Effects of MDMA (3,4-methylenedioxymethamphetamine) in Social Cognition in Borderline Personality Disorder

Phase: PHASE2 | Sponsor: Yale University | Compound: MDMA

Status

recruiting

Institution

Yale University

Start date

2025-09-05

End date

2026-06-01

Registry ID

NCT06683014

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.